BridgeBio Oncology Therapeutics Inc Com rose 16.4% on Wednesday, November 11, 2026, on 1,423,700 shares, 2.3 times its average daily volume. The headline around the move:
BridgeBio Oncology Therapeutics Inc Com (BBOT:NASDAQ) closed at $2.14 on November 13, 2026, down 8.94% on the day. The stock trades 85.6% below its 52-week high of $14.87 and 8.1% above its 52-week low of $1.98. Over the past year, it lost 84.4%. BridgeBio Oncology Therapeutics Inc Com is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, BBOT closed higher on 103 days (41%). Its best day was December 5, 2025 (+18.63%) and its worst was September 9, 2026 (-23.76%). The stock moved 10% or more in a single session 11 times.
BridgeBio Oncology Therapeutics, Inc. is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies. BBOT has the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors. For more information, visit bbotx.com.
Find more stocks like BBOT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.